Hematopoietic stem cell transplantation (HSCT) with a conditioning regimen of busulfan, cyclophosphamide and etoposide for children with acute myelogenous leukemia (AML): A phase I study of the Pediatric Blood and Marrow Transplant Consortium.
Document Type
Journal Article
Publication Date
2000
Journal
Medical and Pediatric Oncology
Volume
35
Issue
4
Inclusive Pages
403-409
Keywords
Pediatrics
APA Citation
Sandler, E., Haag, R., Coppes, M., Mustafa, M., & Gamis, A. (2000). Hematopoietic stem cell transplantation (HSCT) with a conditioning regimen of busulfan, cyclophosphamide and etoposide for children with acute myelogenous leukemia (AML): A phase I study of the Pediatric Blood and Marrow Transplant Consortium.. Medical and Pediatric Oncology, 35 (4). Retrieved from https://hsrc.himmelfarb.gwu.edu/smhs_peds_facpubs/3444
COinS